We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+11.19%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$495M
AUM Growth
+$42.3M
(+9.3%)
Cap. Flow
+$9.1M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
29.63%
Holding
118
New
15
Increased
40
Reduced
35
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$11.4M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$6.57M |
| 3 |
Edwards Lifesciences
EW
|
+$5.77M |
| 4 |
NXP Semiconductors
NXPI
|
+$5.58M |
| 5 |
CSX Corp
CSX
|
+$5.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$11.4M |
| 2 |
LyondellBasell Industries
LYB
|
+$11.2M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$9.56M |
| 4 |
Qualcomm
QCOM
|
+$7.11M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$6.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.39% |
| 2 | Technology | 14.51% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Industrials | 12.41% |
| 5 | Financials | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
America Movil
AMX
$78.3B
| $237K | 0.05% |
10,710
-300
| -3% | -$6.99K |
|
102
Ecolab
ECL
$75.1B
| $235K | 0.05% |
2,250
| – | – |
|
103
GE Aerospace
GE
$370B
| $235K | 0.05% |
1,941
-208
| -10% | -$25.6K |
|
104
US Bancorp
USB
$99.1B
| $234K | 0.05% |
5,209
| – | – |
|
105
Abbott
ABT
$180B
| $220K | 0.04% |
4,900
-100
| -2% | -$4.36K |
|
106
Oracle
ORCL
$336B
| $206K | 0.04% |
4,600
-1,400
| -23% | -$57K |
|
|
GCVRZ
107
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $31K | 0.01% |
39,800
| – | – |
|
108
Capri Holdings
CPRI
$1.77B
| – | – |
-7,100
| Closed | -$507K |
|
|
109
Alphabet (Google) Class C
GOOG
$3.89T
| – | – |
-389,306
| Closed | -$11.4M |
|
110
W.W. Grainger
GWW
$64.6B
| – | – |
-13,700
| Closed | -$3.45M |
|
111
IBM
IBM
$200B
| – | – |
-2,338
| Closed | -$424K |
|
112
Johnson & Johnson
JNJ
$633B
| – | – |
-3,200
| Closed | -$341K |
|
|
113
LyondellBasell Industries
LYB
$19.7B
| – | – |
-103,000
| Closed | -$11.2M |
|
114
Myriad Genetics
MYGN
$528M
| – | – |
-129,300
| Closed | -$4.99M |
|
115
United Rentals
URI
$70.3B
| – | – |
-58,000
| Closed | -$6.44M |
|
|
SLCA
116
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| – | – |
-54,000
| Closed | -$3.38M |
|
|
WFT
117
DELISTED
Weatherford International plc
WFT
| – | – |
-155,000
| Closed | -$3.22M |
|
|
BHI
118
DELISTED
Baker Hughes
BHI
| – | – |
-45,600
| Closed | -$2.97M |
|
Similar funds
ECA
DWML
BOA
PLU
CPW
CAAM
SCP
EFMC
De Burlo Group's Q4 2014 Portfolio in Review
As of Q4 2014, De Burlo Group held 118 positions worth $495M, up 9.3% from $452M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
De Burlo Group's Q4 2014 filing shows 15 new, 40 increased, 35 reduced and 11 closed positions. Its largest new stake was Allergan plc: 45,570 shares worth $11.7M. The largest sale was Alphabet (Google) Class C, an estimated $11.4M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
- De Burlo Group's largest Q4 2014 buy was Allergan plc: 45,570 shares worth $11.7M.
- De Burlo Group added most to Nike in Q4 2014, an estimated $5.09M increase.
- De Burlo Group's biggest Q4 2014 reduction was SALIX PHARMACEUTICALS LTD DEL, cutting an estimated $9.56M.
- De Burlo Group fully exited Alphabet (Google) Class C in Q4 2014, selling an estimated $11.4M.
- De Burlo Group's ten largest holdings make up 30% of its $495M portfolio in Q4 2014.
- De Burlo Group opened 15 new positions and closed 11 in Q4 2014.
- De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $495M.
Based on De Burlo Group's 13F filing for Q4 2014, filed 12 Feb 2015.